Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

导出原文传递

翻译打印收藏纠错

作者： Srivastava, Shashikant ^[1] ; Deshpande, Devyani ^[2] ; Magombedze, Gesham ^[3] ; van Zyl, Johanna ^[4] ; Cirrincione, Kayle ; Martin, Katherine ; Bendet, Paula ; Berg, Alexander ; Hanna, Debra ; Romero, Klaus ; Hermann, Dave ; Gumbo, Tawanda

作者单位： Crit Path Inst, Crit Path TB Drug Regimens, Tucson, AZ USA ^[1] Praedicare Labs, Dallas, TX USA ^[2] Bill & Melinda Gates Fdn, Seattle, WA USA ^[3] Baylor Univ, Med Ctr, Baylor Res Inst, Ctr Infect Dis Res & Expt Therapeut, Dallas, TX USA ^[4]

发布时间 2021-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Antimicrobial Chemotherapy

2020年75卷2期

392-399页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

The Journal of Antimicrobial Chemotherapy

相似文献

The Journal of Antimicrobial Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics

The Journal of Antimicrobial Chemotherapy

相似文献

The Journal of Antimicrobial Chemotherapy

相关期刊

检索历史清除